Fabio Palombo

Company: NeoMatrix

Job title: Chief scientific officer

Seminars:

Improved Feasibility & Efficacy of Synthetic DNA for Personalized Cancer Vaccines 3:00 pm

Reviewing key features that make neoantigen anti-cancer vaccines attractive such as their ability to stimulate an immune response that targets the patient’s specific tumor Why personalized neoantigen vaccines have the potential to be more targeted and less toxic compared to traditional cancer treatments, which can often have harmful side effects and are not always effective…Read more

day: Pre-Conference Focus Day